Healthcare >> CEO Interviews >> July 5, 2004
DAVID FREEDMAN serves as Chairman of the Board of Directors of New
Brunswick Scientific Co. He has held this position since the corporation
was incorporated in 1958. Mr. Freedman previously served as President
and Chief Executive Officer of the corporation until his resignation
from that position on May 1, 1989. Mr. Freedman was reappointed as Chief
Executive Officer in 2000. Mr. Freedman is also a Director of PharmaSeq,
Inc., a privately held company. Profile
Co. and your products?
Mr. Freedman: New Brunswick Scientific is an integrated engineering,
manufacturing and marketing
